Johnson & Johnson proposes $6.5B settlement to resolve talc cancer claims
Under the terms, the New Brunswick-based pharmaceutical and medical technologies company would resolve the cases through a third bankruptcy filing of LTL Management, a subsidiary company previously created to absorb talc liability.